Antioxidant effects and insulin resistance improvement of chromium combined with vitamin C and e supplementation for type 2 diabetes mellitus.
about
Molecular mechanisms of chromium in alleviating insulin resistanceAntioxidant micronutrients and cardiovascular risk in patients with diabetes: a systematic reviewTrace elements in glucometabolic disorders: an update.Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes.Effects of the interaction of diabetes and iron supplementation on hepatic and pancreatic tissues, oxidative stress markers, and liver peroxisome proliferator-activated receptor-α expression.Effect of chromium supplementation on glycated hemoglobin and fasting plasma glucose in patients with diabetes mellitusThe effect of Omega-3 fatty acids on serum paraoxonase activity, vitamins A, E, and C in type 2 diabetic patientsHoney--a novel antidiabetic agent.Chromium supplements for glycemic control in type 2 diabetes: limited evidence of effectivenessThe role of antioxidants and other agents in alleviating hyperglycemia mediated oxidative stress and injury in liver.Effect of vitamins C and E on insulin resistance in diabetes: a meta-analysis study.Therapeutic effects of soy isoflavones on α-amylase activity, insulin deficiency, liver-kidney function and metabolic disorders in diabetic rats.Vitamin E Improves Serum Paraoxonase-1 Activity and Some Metabolic Factors in Patients with Type 2 Diabetes: No Effects on Nitrite/Nitrate Levels.Management of diabetes mellitus: could simultaneous targeting of hyperglycemia and oxidative stress be a better panacea?Effect of ascorbic acid and alpha-tocopherol supplementations on serum leptin, tumor necrosis factor alpha, and serum amyloid A levels in individuals with type 2 diabetes mellitus.Ameliorating effect of chromium administration on hepatic glucose metabolism in streptozotocin-induced experimental diabetes.Oxidative stress and antioxidant capacity in patients with chronic pancreatitis with and without diabetes mellitus.Trivalent chromium inhibits TSP-1 expression, proliferation, and O-GlcNAc signaling in vascular smooth muscle cells in response to high glucose in vitro.Antioxidant effects of vitamins in type 2 diabetes: a meta-analysis of randomized controlled trials.Biochemical Mechanisms
P2860
Q28262068-A7C072BD-8D0F-46E7-A57C-E7BEA3C58D34Q33655078-C496CEF5-30DA-40AB-93CE-973BEB9C60D0Q34504189-2303CDF1-1812-40ED-9AF5-0C5F2DBB3547Q35122357-0411B9C0-C765-452A-8724-A9F3F2512781Q35209655-EB620501-FB72-492B-BD93-E694880EEDD5Q35601489-AB06474D-B0DE-4633-A3AE-F8A2676C083EQ35686088-5B3357F0-E6FB-40F9-8DF8-88FDFD637708Q36101651-131B7B15-E47A-435F-AF4E-DDC71352F123Q37228180-03010E5A-68E1-4EE1-BAD4-2FCE4EF17C3AQ38113967-8CF7AA34-47CF-4871-8633-517322C1FA47Q38574961-1E00CDFA-29F4-42E5-9958-CF3BCA0EEB79Q39813371-49A8E7E8-6B0D-4F55-B62B-94BE378C75D1Q39990492-73148BE1-B474-4B0B-944A-0CED74D55CD7Q41847652-67B270A2-7802-4585-9D55-DC19D3B6D735Q41988736-5C18596A-71C3-4D68-AB19-4E6AF4599708Q42721900-9CFCC3B5-589D-4140-9D2B-81AE1A63C89AQ43409013-6381FBFE-2309-48E2-AB4F-6FF3BC7C3C00Q46820224-E52CF922-3C99-4C6A-99A6-C274377AB28EQ51736297-08A32B6D-41AA-4738-AD4A-B621396E6847Q57602266-61A579E1-3F18-4CD3-8885-5F6864C41051
P2860
Antioxidant effects and insulin resistance improvement of chromium combined with vitamin C and e supplementation for type 2 diabetes mellitus.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Antioxidant effects and insuli ...... for type 2 diabetes mellitus.
@en
Antioxidant effects and insuli ...... for type 2 diabetes mellitus.
@nl
type
label
Antioxidant effects and insuli ...... for type 2 diabetes mellitus.
@en
Antioxidant effects and insuli ...... for type 2 diabetes mellitus.
@nl
prefLabel
Antioxidant effects and insuli ...... for type 2 diabetes mellitus.
@en
Antioxidant effects and insuli ...... for type 2 diabetes mellitus.
@nl
P2860
P356
P1476
Antioxidant effects and insuli ...... for type 2 diabetes mellitus.
@en
P2093
Ming-Hoang Lai
P2860
P304
P356
10.3164/JCBN.2008064
P577
2008-10-31T00:00:00Z